LANABIOTIC Drug Patent Profile
When do Lanabiotic patents expire, and when can generic versions of Lanabiotic launch?
Lanabiotic is a drug marketed by Combe and is included in two NDAs.
The generic ingredient in LANABIOTIC is bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate. There are two drug master file entries for this compound. Additional details are available on the bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LANABIOTIC?
- What are the global sales for LANABIOTIC?
- What is Average Wholesale Price for LANABIOTIC?
Summary for LANABIOTIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 124 |
| DailyMed Link: | LANABIOTIC at DailyMed |
US Patents and Regulatory Information for LANABIOTIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combe | LANABIOTIC | bacitracin; polymyxin b sulfate | DISC;TOPICAL | 050598-001 | Sep 22, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Combe | LANABIOTIC | bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate | OINTMENT;TOPICAL | 062499-001 | Jun 3, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
